Oral Solid Dosage Pharmaceutical Formulation Market

Oral Solid Dosage Pharmaceutical Formulation Market: Emerging Markets of Latin America, APEJ and MEA to Collectively Hold over 45% Market Value Share: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

Future Market Insights forecasts the global oral solid dosage pharmaceutical formulation market to grow from US$ 493.2 Bn in 2017 to US$ 926.3 Bn by 2027 end. This represents a value CAGR of 6.5% over the forecast period 2017– 2027. Several important factors drive this growth. We present these factors in detail in our report. A snapshot is captured below for our readers’ benefit.

Growth Factor : Most promising yet cost-effective dosage form

Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well. For instance, oral solid dosage forms are often chosen by patients owing to the inherent advantages in dosage administration and no necessity of dose measurement. They can be formulated in different flavours and in different dosage forms in order to increase patient compliance. For instance, few APIs have unpleasant taste, and in order to avoid this, they are manufactured in the form of effervescent tablets to achieve patient acceptability and compliance. Recent advances in drug delivery are enabling oral solid dosage manufacturers to achieve significant bioavailability by adopting novel drug delivery technology platforms. For example, targeted drug delivery and sustained release of dosage forms in oral solid dosage formulations enhance the bioavailability of the drugs and reduce the frequent administration of drugs, thereby contributing to significant growth of oral solid dosage forms.

Growth Factor : Growth in APEJ region driven by rise in affluent consumers and super generics

Huge boost in the APEJ market for oral solid dosage pharmaceutical formulations is coming from a sharp rise in new affluent consumers in countries such as India, China and Korea. Both multinational companies as well as local drug manufacturers are benefiting from the rapidly growing population of India and China. This group of affluent consumers is adopting a wealthy and fast-paced western lifestyle and thus have begun to suffer with western lifestyle related diseases such as diabetes, cancer and obesity, for which they seek and can afford innovative drug treatments. Moreover, generic manufacturers have entered into the production of super-generics i.e., modified versions of approved off-patent small-molecule drugs that offer a therapeutic advantage and thus distinguish them from me-too generic drugs. For instance, Ranbaxy Laboratories Ltd. – India based manufacturer of generic medicine – has developed once-a day Ciprofloxacin tablet, a super generic antibiotic. The company licensed it to Bayer and opened up an opportunity in the global market.

Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, By Region

North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. North America is expected to be the most lucrative among all regions, with a market attractiveness index of 2.7. Consolidation of the pharmaceutical industry in the U.S. combined with an expansion in outsourcing is boosting revenue growth of the oral solid dosage pharmaceutical formulation market in the region. APEJ is expected to be the second most lucrative market for oral solid dosage pharmaceuticals, with a market attractiveness index of 2.6. APEJ remains the third largest market due to rapidly increasing penetration of generics in China and India. MEA is expected to remain the least attractive regional market in terms of revenue, with a market attractiveness index of 0.1 over the forecast period.

global oral solid dosage pharmaceutical formulation market

Every market is challenged by certain factors that tend to hamper overall growth. We have focussed on these growth limiters in detail in our report. One such factor restraining market growth is highlighted below.

Diminishing share of oral solids in the development pipeline

Growing research on biologics molecules and their dominance in treating oncology conditions are hampering the growth of the oral solid dosage pharmaceutical formulation market. Furthermore, investments by government organisations to conduct research activities in biologics coupled with an increase in biotech start-ups have had a negative impact on oral solid dosage forms. According to an article published in Contract Pharma, approximately 50% of the pipeline molecules are biologics and the rest in the form of other dosage forms. Companies are betting heavily on biologics owing to their high returns in terms of value. For instance, in 2016, the top 10 drugs generated around US$ 79 Bn in terms of value; among these, 76.8% were from biologics.

In this report, historical data, primary responses and public domain data has been thoroughly analysed to infer the market size. Revenue of companies operating in the oral solid dosage pharmaceutical formulation market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to determine the market size for the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and is extensively scrutinised using advanced tools to garner quantitative and qualitative insights into the global oral solid dosage pharmaceutical formulation market.

Market Segmentation

By Dosage Form

By Drug Release Mechanism

By Distribution Channel

By Region

  • Tablets

  • Capsules

  • Powders

  • Others

  • Immediate Release

  • Extended Release

    • Sustained Release

    • Controlled Release

  • Others

  • Hospital Pharmacy

  • Retail Pharmacy

  • Drug Stores

  • Online Pharmacy

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific excluding Japan

  • Japan

  • Middle East and Africa

Report Introduction

As oral solid dosage forms are used across the entire spectrum of pharmaceutical dosage forms, almost every company in the market today is adding oral solids in their products portfolio. Despite an increasing number of biologics in the pipeline, oral solid dosage pharmaceuticals are expected to witness considerable growth due to product lifecycle management strategies employed by manufacturers. Companies are focussing on internal and external capacity expansion, which ultimately increases contract development and manufacturing activities across the globe.

Report Structure

Introduction: This section includes:

  • Pertinent market numbers of the global oral solid dosage pharmaceutical formulation market along with the CAGR for the forecast period 2017-2027

  • Detailed definitions of oral solid dosage pharmaceutical formulations, which gives clarity about what this market is all about and also defines the scope of this report

  • Macroeconomic factors influencing the global oral solid dosage pharmaceutical formulation market, along with market opportunity analysis

  • Key trends likely to impact the global oral solid dosage pharmaceutical formulation market

Regional market analysis and forecast: This section focusses on:

  • Regional oral solid dosage pharmaceutical formulation market analysis and forecast

  • Regional market dynamics including the drivers, restraints and trends applicable across different regions in the oral solid dosage pharmaceutical formulation market along with factors encouraging the growth of this market as well as the factors hampering the growth of this market

  • Regional trends – both long term and short term

Competitive landscape: This section presents:

  • the competitive landscape of the global oral solid dosage pharmaceutical formulation market

  • information on the various leading companies in the global oral solid dosage pharmaceutical formulation market

  • a dashboard view of the key companies operating in the global oral solid dosage pharmaceutical formulation market along with their important information and broad strategy adopted to stay as leaders in the global oral solid dosage pharmaceutical formulation market

  • key company profiles along with important information such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis

Global market analysis and forecast: The last section of the report highlights:

  • the global oral solid dosage pharmaceutical formulation market analysis and forecast by dosage form, drug release mechanism, distribution channel and region

  • key market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the global oral solid dosage pharmaceutical formulation market

Why should you invest in this report?

If you are aiming to enter the global oral solid dosage pharmaceutical formulation market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for oral solid dosage pharmaceutical formulations are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2017-2027, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable. 

Oral Solid Dosage Pharmaceutical Formulation Market Reports - Table of Contents

1.Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2.Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3.Oral Solid Dosage Pharmaceuticals Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4.North America Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1.Drivers

4.2.2.Restraints

4.2.3.Trends

4.3. Historical Market Size (US$ Mn) By Country, 2012-2016

4.3.1.U.S.

4.3.2.Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1.U.S.

4.4.2.Canada

4.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

4.5.1.Tablets

4.5.2.Capsules

4.5.3.Powders

4.5.4.Others

4.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

4.6.1.Tablets

4.6.2.Capsules

4.6.3.Powders

4.6.4.Others

4.7. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

4.7.1.Immediate Release

4.7.2.Extended Release

4.7.2.1. Sustained Release

4.7.2.2. Controlled Release

4.7.3.Others

4.8. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

4.8.1.Immediate Release

4.8.2.Extended Release

4.8.2.1. Sustained Release

4.8.2.2. Controlled Release

4.8.3.Others

4.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

4.9.1.Hospital Pharmacy

4.9.2.Retail Pharmacy

4.9.3.Drug Stores

4.9.4.Online Pharmacy

4.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

4.10.1.Hospital Pharmacy

4.10.2.Retail Pharmacy

4.10.3.Drug Stores

4.10.4.Online Pharmacy

4.11. Drivers and Restraints: Impact Analysis

4.12. Market Attractiveness Analysis

4.12.1.By Country

4.12.2.By Dosage Form

4.12.3.By Drug Release Mechanism

4.12.4.By Distribution Channel

4.13. Key Representative Market Participants

4.14. Key Participants Market Presence (Intensity Map)

5.Western Europe Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1.Drivers

5.2.2.Restraints

5.2.3.Trends

5.3. Historical Market Size (US$ Mn) By Country, 2012-2016

5.3.1.Germany

5.3.2.U.K

5.3.3.France

5.3.4.Italy

5.3.5.Spain

5.3.6.Rest of Western Europe

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1.Germany

5.4.2.U.K

5.4.3.France

5.4.4.Italy

5.4.5.Spain

5.4.6.Rest of Western Europe

5.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

5.5.1.Tablets

5.5.2.Capsules

5.5.3.Powders

5.5.4.Others

5.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

5.6.1.Tablets

5.6.2.Capsules

5.6.3.Powders

5.6.4.Others

5.7. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

5.7.1.Immediate Release

5.7.2.Extended Release

5.7.2.1. Sustained Release

5.7.2.2. Controlled Release

5.7.3.Others

5.8. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

5.8.1.Immediate Release

5.8.2.Extended Release

5.8.2.1. Sustained Release

5.8.2.2. Controlled Release

5.8.3.Others

5.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

5.9.1.Hospital Pharmacy

5.9.2.Retail Pharmacy

5.9.3.Drug Stores

5.9.4.Online Pharmacy

5.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

5.10.1.Hospital Pharmacy

5.10.2.Retail Pharmacy

5.10.3.Drug Stores

5.10.4.Online Pharmacy

5.11. Drivers and Restraints: Impact Analysis

5.12. Market Attractiveness Analysis

5.12.1.By Country

5.12.2.By Dosage Form

5.12.3.By Drug Release Mechanism

5.12.4.By Distribution Channel

5.13. Key Representative Market Participants

5.14. Key Participants Market Presence (Intensity Map)

6.Eastern Europe Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1.Drivers

6.2.2.Restraints

6.2.3.Trends

6.3. Historical Market Size (US$ Mn) By Country, 2012-2016

6.3.1.Russia

6.3.2.Poland

6.3.3.Rest of Eastern Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1.Russia

6.4.2.Poland

6.4.3.Rest of Eastern Europe

6.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

6.5.1.Tablets

6.5.2.Capsules

6.5.3.Powders

6.5.4.Others

6.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

6.6.1.Tablets

6.6.2.Capsules

6.6.3.Powders

6.6.4.Others

6.7. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

6.7.1.Immediate Release

6.7.2.Extended Release

6.7.2.1. Sustained Release

6.7.2.2. Controlled Release

6.7.3.Others

6.8. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

6.8.1.Immediate Release

6.8.2.Extended Release

6.8.2.1. Sustained Release

6.8.2.2. Controlled Release

6.8.3.Others

6.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

6.9.1.Hospital Pharmacy

6.9.2.Retail Pharmacy

6.9.3.Drug Stores

6.9.4.Online Pharmacy

6.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

6.10.1.Hospital Pharmacy

6.10.2.Retail Pharmacy

6.10.3.Drug Stores

6.10.4.Online Pharmacy

6.11. Drivers and Restraints: Impact Analysis

6.12. Market Attractiveness Analysis

6.12.1.By Country

6.12.2.By Dosage Form

6.12.3.By Drug Release Mechanism

6.12.4.By Distribution Channel

6.13. Key Representative Market Participants

6.14. Key Participants Market Presence (Intensity Map)

7.Latin America Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1.Drivers

7.2.2.Restraints

7.2.3.Trends

7.3. Historical Market Size (US$ Mn) By Country, 2012-2016

7.3.1.Brazil

7.3.2.Mexico

7.3.3.Rest of Latin America

7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

7.4.1.Brazil

7.4.2.Mexico

7.4.3.Rest of Latin America

7.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

7.5.1.Tablets

7.5.2.Capsules

7.5.3.Powders

7.5.4.Others

7.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

7.6.1.Tablets

7.6.2.Capsules

7.6.3.Powders

7.6.4.Others

7.7. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

7.7.1.Immediate Release

7.7.2.Extended Release

7.7.2.1. Sustained Release

7.7.2.2. Controlled Release

7.7.3.Others

7.8. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

7.8.1.Immediate Release

7.8.2.Extended Release

7.8.2.1. Sustained Release

7.8.2.2. Controlled Release

7.8.3.Others

7.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

7.9.1.Hospital Pharmacy

7.9.2.Retail Pharmacy

7.9.3.Drug Stores

7.9.4.Online Pharmacy

7.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

7.10.1.Hospital Pharmacy

7.10.2.Retail Pharmacy

7.10.3.Drug Stores

7.10.4.Online Pharmacy

7.11. Drivers and Restraints: Impact Analysis

7.12. Market Attractiveness Analysis

7.12.1.By Country

7.12.2.By Dosage Form

7.12.3.By Drug Release Mechanism

7.12.4.By Distribution Channel

7.13. Key Representative Market Participants

7.14. Key Participants Market Presence (Intensity Map)

8.Asia Pacific Excluding Japan Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1.Drivers

8.2.2.Restraints

8.2.3.Trends

8.3. Historical Market Size (US$ Mn) By Country, 2012-2016

8.3.1.China

8.3.2.India

8.3.3.Australia and New Zealand

8.3.4.ASEAN

8.3.5.Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

8.4.1.China

8.4.2.India

8.4.3.Australia and New Zealand

8.4.4.ASEAN

8.4.5.Rest of APEJ

8.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

8.5.1.Tablets

8.5.2.Capsules

8.5.3.Powders

8.5.4.Others

8.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

8.6.1.Tablets

8.6.2.Capsules

8.6.3.Powders

8.6.4.Others

8.7. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

8.7.1.Immediate Release

8.7.2.Extended Release

8.7.2.1. Sustained Release

8.7.2.2. Controlled Release

8.7.3.Others

8.8. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

8.8.1.Immediate Release

8.8.2.Extended Release

8.8.2.1. Sustained Release

8.8.2.2. Controlled Release

8.8.3.Others

8.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

8.9.1.Hospital Pharmacy

8.9.2.Retail Pharmacy

8.9.3.Drug Stores

8.9.4.Online Pharmacy

8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

8.10.1.Hospital Pharmacy

8.10.2.Retail Pharmacy

8.10.3.Drug Stores

8.10.4.Online Pharmacy

8.11. Drivers and Restraints: Impact Analysis

8.12. Market Attractiveness Analysis

8.12.1.By Country

8.12.2.By Dosage Form

8.12.3.By Drug Release Mechanism

8.12.4.By Distribution Channel

8.13. Key Representative Market Participants

8.14. Key Participants Market Presence (Intensity Map)

9.Japan Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1.Drivers

9.2.2.Restraints

9.2.3.Trends

9.3. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

9.3.1.Tablets

9.3.2.Capsules

9.3.3.Powders

9.3.4.Others

9.4. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

9.4.1.Tablets

9.4.2.Capsules

9.4.3.Powders

9.4.4.Others

9.5. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

9.5.1.Immediate Release

9.5.2.Extended Release

9.5.2.1. Sustained Release

9.5.2.2. Controlled Release

9.5.3.Others

9.6. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

9.6.1.Immediate Release

9.6.2.Extended Release

9.6.2.1. Sustained Release

9.6.2.2. Controlled Release

9.6.3.Others

9.7. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

9.7.1.Hospital Pharmacy

9.7.2.Retail Pharmacy

9.7.3.Drug Stores

9.7.4.Online Pharmacy

9.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

9.8.1.Hospital Pharmacy

9.8.2.Retail Pharmacy

9.8.3.Drug Stores

9.8.4.Online Pharmacy

9.9. Drivers and Restraints: Impact Analysis

9.10. Market Attractiveness Analysis

9.10.1.By Dosage Form

9.10.2.By Drug Release Mechanism

9.10.3.By Distribution Channel

9.11. Key Representative Market Participants

9.12. Key Participants Market Presence (Intensity Map)

10. Middle East and Africa Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1.Drivers

10.2.2.Restraints

10.2.3.Trends

10.3. Historical Market Size (US$ Mn) By Country, 2012-2016

10.3.1.GCC Countries

10.3.2.South Africa

10.3.3.Rest of Middle East and Africa

10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

10.4.1.GCC Countries

10.4.2.South Africa

10.4.3.Rest of Middle East and Africa

10.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

10.5.1.Tablets

10.5.2.Capsules

10.5.3.Powders

10.5.4.Others

10.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

10.6.1.Tablets

10.6.2.Capsules

10.6.3.Powders

10.6.4.Others

10.7. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

10.7.1.Immediate Release

10.7.2.Extended Release

10.7.2.1.Sustained Release

10.7.2.2.Controlled Release

10.7.3.Others

10.8. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

10.8.1.Immediate Release

10.8.2.Extended Release

10.8.2.1.Sustained Release

10.8.2.2.Controlled Release

10.8.3.Others

10.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

10.9.1.Hospital Pharmacy

10.9.2.Retail Pharmacy

10.9.3.Drug Stores

10.9.4.Online Pharmacy

10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

10.10.1.Hospital Pharmacy

10.10.2.Retail Pharmacy

10.10.3.Drug Stores

10.10.4.Online Pharmacy

10.11. Drivers and Restraints: Impact Analysis

10.12. Market Attractiveness Analysis

10.12.1.By Country

10.12.2.By Dosage Form

10.12.3.By Drug Release Mechanism

10.12.4.By Distribution Channel

10.13. Key Representative Market Participants

10.14. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Market Structure

13.2. Competition Intensity Mapping By Market Taxonomy

13.3. Competition Dashboard

13.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

13.4.1.AstraZeneca Plc.

13.4.2.Bristol-Myers Squibb Company

13.4.3.Eli Lilly and Company

13.4.4.Gilead Sciences

13.4.5.Merck & Co. Inc.

13.4.6.Novartis AG

13.4.7.Pfizer Inc.

13.4.8.AbbVie Inc.

13.4.9. Boehringer Ingelheim GmbH

13.4.10.Hoffman-La-Roche Ltd. 

13.4.11. Johnson & Johnson 

13.4.12. Biogen Inc.

13.4..13. Bayer AG

13.5.14. Teva Pharmaceticals

13.5.15. Amgen Inc.

13.5.16. Takeda Pharmaceutical Company Ltd.

13.5.17. Otsuka Pharmaceutical Co., Ltd.

13.5.18. Shire Plc.

13.5.19. Celgene Corporation

13.5.20. Astellas Pharma Inc.

14. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027 By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) By Region

14.2.1.North America

14.2.2.Western Europe

14.2.3.Eastern Europe

14.2.4.Latin America

14.2.5.Asia Pacific Excluding Japan

14.2.6.Japan

14.2.7.Middle East and Africa

14.3. Market Size (US$ Mn) Forecast By Region

14.3.1.North America

14.3.2.Western Europe

14.3.3.Eastern Europe

14.3.4.Latin America

14.3.5.Asia Pacific Excluding Japan

14.3.6.Japan

14.3.7.Middle East and Africa

14.4. Market Attractiveness Analysis By Region

15. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027, By Dosage Form

15.1. Introduction/Key Finding

15.2. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

15.2.1.Tablets

15.2.2.Capsules

15.2.3.Powders

15.2.4.Others

15.3. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

15.3.1.Tablets

15.3.2.Capsules

15.3.3.Powders

15.3.4.Others

15.4. Key Trends / Developments

15.5. Drivers and Restraints: Impact Analysis

15.6. Market Attractiveness Analysis By Dosage Form Type

16. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Release Mechanism

16.1.Introduction/Key Finding

16.2. Historical Market Size (US$ Mn) By Drug Release Mechanism, 2012-2016

16.2.1.Immediate Release

16.2.2.Extended Release

16.2.2.1.Sustained Release

16.2.2.2.Controlled Release

16.2.3.Others

16.3. Market Size (US$ Mn) Forecast By Drug Release Mechanism, 2017-2017

16.3.1.Immediate Release

16.3.2.Extended Release

16.3.2.1.Sustained Release

16.3.2.2.Controlled Release

16.3.3.Others

16.4. Key Trends / Developments

16.5. Drivers and Restraints: Impact Analysis

16.6.Market Attractiveness Analysis By Drug Release Mechanism

17. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

17.1. Introduction/Key Finding

17.2. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

17.2.1.Hospital Pharmacy

17.2.2.Retail Pharmacy

17.2.3.Drug Stores

17.2.4.Online Pharmacy

17.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

17.3.1.Hospital Pharmacy

17.3.2.Retail Pharmacy

17.3.3.Drug Stores

17.3.4.Online Pharmacy

17.4. Drivers and Restraints: Impact Analysis

17.5. Market Attractiveness Analysis By Distribution Channel

18. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

18.1. Market Size and Y-o-Y Growth

18.2. Absolute $ Opportunity

18.3. Value Chain

19. Assumptions and Acronyms Used

20. Research Methodology

Oral Solid Dosage Pharmaceutical Formulation Market Reports - List of Tables

Table 01: North America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 02: North America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 03: North America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 04: North America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 05: Western Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 06: Western Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 07: Western Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 08: Western Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 09: Eastern Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 10: Eastern Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 11: Eastern Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 12: Eastern Europe Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 13: Latin America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 14: Latin America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 15: Latin America Oral Solid Dosage Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 16: Latin America Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 17: APEJ Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 18: APEJ Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 19: APEJ Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 20: APEJ Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 21: Japan Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 22: Japan Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 23: Japan Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 24: MEA Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 25: MEA Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 26: MEA Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 27: MEA Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Table 28: Global Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Region (2012-2027)

Table 29: Global Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Table 30: Global Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Release Mechanism (2012-2027)

Table 31: Global Oral Solid Dosage Pharmaceuticals Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2012-2027)

Oral Solid Dosage Pharmaceutical Formulation Market Reports - List of Figures

Figure 01: North America Oral Solid Dosage Pharmaceuticals Historical Market Size and Y-o-Y, 2012 - 2016

Figure 02: North America Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y analysis, 2016 - 2027

Figure 03: North America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Country, 2017–2027

Figure 04: North America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 05: North America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 06: North America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 07: Western Europe Oral Solid Dosage Pharmaceuticals Historical Market Size % Y-o-Y, 2012 - 2016

Figure 08: Western Europe Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) Y-o-Y analysis, 2016 - 2027

Figure 09: Western Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Country, 2017–2027

Figure 10: Western Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 11: Western Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 12: Western Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 13: Eastern Europe Oral Solid Dosage Pharmaceuticals Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 14: Eastern Europe Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 15: Eastern Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Country, 2017–2027

Figure 16: Eastern Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 17: Eastern Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 18: Eastern Europe Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 19: Latin America Oral Solid Dosage Pharmaceuticals Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 20: Latin America Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 21: Latin America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Country, 2017–2027

Figure 22: Latin America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 23: Latin America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 24: Latin America Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 25: APEJ Oral Solid Dosage Pharmaceuticals Historical Market Size & Y-o-Y Analysis 2012 - 2016

Figure 26: APEJ Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 27: APEJ Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Country, 2017–2027

Figure 28: APEJ Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 29: APEJ Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 30: APEJ Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 31: Japan Oral Solid Dosage Pharmaceuticals Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 32: Japan Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 33: Japan Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 34: Japan Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 35: Japan Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 36: MEA Oral Solid Dosage Pharmaceuticals Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 37: MEA Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 38: MEA Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Country, 2017–2027

Figure 39: MEA Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 40: MEA Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Release Mechanism, 2017–2027

Figure 41: MEA Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis By Distribution Channel, 2017–2027

Figure 42: Global Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis, By Region

Figure 43: Global Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis, By Dosage Form

Figure 44: Global Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis, By Release Mechanism

Figure 45: Global Oral Solid Dosage Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel

Figure 46: Global Oral Solid Dosage Pharmaceuticals Market Historical Market Size and Y-o-Y, 2012 - 2016

Figure 47: Global Oral Solid Dosage Pharmaceuticals Projected Market Size (US$ Mn) and Y-o-Y, 2017 - 2027

Figure 48: Global Oral Solid Dosage Pharmaceuticals Market Absolute $ Opportunity, 2012–2027